KFDA’s drug-related committee urged to provide more information

The Korea Food and Drug Administration should provide key information on its Central Pharmaceutical Affairs Review Committee (CPARC) for selection of committee members and for details of various meetings.

So far, the KFDA has been given advice from the CPARC for a variety of drug-related administrative affairs.

During the last parliamentary audit to the drug agency last week, Rep. Park Eu...